This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Ucl Business Plc. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Fiyaz Mohammed: Innovator in T Cell Receptor Engineering
Introduction
Fiyaz Mohammed is a notable inventor based in Birmingham, GB. He has made significant contributions to the field of immunology, particularly in the engineering of T cell receptors. With a total of 2 patents to his name, his work is paving the way for advancements in therapeutic applications.
Latest Patents
Fiyaz's latest patents focus on engineered T cell receptors (TCRs). One of his inventions provides an engineered T cell receptor comprising specific amino acid residues that are not present in the corresponding germline TCR amino acid sequence. This innovation aims to enhance the expression and functionality of TCRs when expressed as exogenous TCRs. The methods outlined in his patents also include techniques for selecting TCRs with high cell surface expression, which is crucial for effective therapeutic applications.
Career Highlights
Throughout his career, Fiyaz has worked with reputable organizations, including UCL Business Plc and UCL Business Ltd. His experience in these companies has allowed him to collaborate with other experts in the field and further his research in T cell receptor engineering.
Collaborations
Fiyaz has collaborated with notable colleagues such as Sharyn Thomas and Ben Willcox. These partnerships have contributed to the development and refinement of his innovative ideas in T cell receptor technology.
Conclusion
Fiyaz Mohammed is a pioneering inventor whose work in engineered T cell receptors is making a significant impact in the field of immunology. His patents and collaborations reflect his commitment to advancing therapeutic solutions.